|
ANNX
|
Annexon, Inc.
|
US
|
NASDAQ
|
|
ATNM
|
Actinium Pharmaceuticals, Inc.
|
US
|
AMEX
|
|
BBLG
|
Bone Biologics Corp
|
US
|
NASDAQ
|
|
COLL
|
Collegium Pharmaceutical, Inc.
|
US
|
NASDAQ
|
|
GNTA
|
Genenta Science S.p.A.
|
US
|
NASDAQ
|
|
IBIO
|
iBio, Inc.
|
US
|
AMEX
|
|
ICVX
|
Icosavax, Inc.
|
US
|
NASDAQ
|
|
IPWR
|
Ideal Power Inc.
|
US
|
NASDAQ
|
|
JANX
|
Janux Therapeutics, Inc.
|
US
|
NASDAQ
|
|
NSPR
|
InspireMD, Inc.
|
US
|
NASDAQ
|
|
OCUL
|
Ocular Therapeutix, Inc.
|
US
|
NASDAQ
|
|
RCEL
|
Avita Medical Limited
|
US
|
NASDAQ
|
|
SRAX
|
Social Reality, Inc.
|
US
|
NASDAQ
|
|
AVE
|
Avecho Biotechnology Limited
|
AU
|
ASX
|
|
BGT
|
Bio-Gene Technology Ltd
|
AU
|
ASX
|
|
GSS
|
Genetic Signatures Ltd
|
AU
|
ASX
|
|
LBT
|
LBT Innovations Limited
|
AU
|
ASX
|
|
NTI
|
Neurotech International Ltd
|
AU
|
ASX
|
|
VBS
|
Vectus Biosystems Ltd
|
AU
|
ASX
|
|
APVS
|
Guardian Tech Intl
|
US
|
OTC
|